us raise concern over tamiflu resistance, page-5

It's this very reason that countries (like the UK did recently) will look into diversifying their anti-viral stockpiles to include Relenza. If only Relenza was a pill!

"But this year its cousin, a seasonal H1N1 strain, became mostly resistant to the most commonly used antiviral -- Roche AG's Tamiflu. GlaxoSmithKline's Relenza, an inhaled drug, still works."

Looking forward LANI (if it passes trials and gets approved) would be yet another weapon against the flu. Having many advantages to current treatments such as once only treatment and potential nebulized delivery the drug could gain a large chunk of market share.

Only weeks now before we see LANI. We may even get some news on DS testing it against the swine flu as we did for H5N1 bird flu.